The Cat Health Company has secured additional $1.2 million in financing to fuel the company’s groundbreaking work in longevity therapeutics, with a focus on helping cats have longer and healthier lives.
Portfolia’s Active Aging & Longevity Fund II has invested in this round alongside Sonia Arrison’s 100 Plus Capital, Alex Zhavoronkov (Insilico Medicine), and a syndicated angel SPV. Early Game Ventures also provided strong follow-on capital.
This is more than just an investment; it’s a vote of confidence in our mission to bring true longevity solutions for the veterinary world
Alex Voda, CEO of The Cat Health Company
Encouraging interim results from clinical trials validated the company’s approach and reinforced its pipeline, attracting significant attention from key players in the longevity space who chose to lead this SAFE round.
